KRAS G12D (Q28371012)

From Wikidata

Jump to navigation Jump to search

genetic variant

GLY12ASP
G12D
RS121913529

Language	Label	Description	Also known as
English	KRAS G12D	genetic variant	GLY12ASP G12D RS121913529

Statements

missense mutation

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

human chromosome 12

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

25398284

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

25398284

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

biological variant of

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

positive therapeutic predictor for

determination method

CIViC evidence level C

CIViC 2-star trust rating

medical condition treated

pancreatic carcinoma

1 reference

23 September 2019

https://civic.genome.wustl.edu/links/evidence/937

First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors

negative therapeutic predictor for

determination method

CIViC evidence level C

CIViC 2-star trust rating

medical condition treated

hairy cell leukemia

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/1580

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

determination method

CIViC evidence level B

CIViC 2-star trust rating

medical condition treated

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/2240

PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients.

determination method

CIViC evidence level C

CIViC 2-star trust rating

medical condition treated

colorectal cancer

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/6316

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

determination method

CIViC evidence level C

CIViC 2-star trust rating

medical condition treated

colorectal cancer

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/6316

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

determination method

CIViC evidence level B

CIViC 2-star trust rating

medical condition treated

multiple myeloma

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/2247

Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation

determination method

CIViC evidence level D

CIViC 2-star trust rating

medical condition treated

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/3957

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

determination method

CIViC evidence level D

CIViC 3-star trust rating

medical condition treated

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/3958

Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations

determination method

CIViC evidence level D

CIViC 1-star trust rating

medical condition treated

colorectal cancer

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/3946

KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer

determination method

CIViC evidence level C

CIViC 3-star trust rating

medical condition treated

colorectal cancer

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/2193

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

determination method

CIViC evidence level B

CIViC 3-star trust rating

medical condition treated

colorectal cancer

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/2207

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

positive diagnostic predictor for

determination method

CIViC evidence level B

CIViC 3-star trust rating

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/228

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers

positive prognostic predictor for

colorectal cancer

determination method

CIViC evidence level B

CIViC 3-star trust rating

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/1215

Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.

negative prognostic predictor for

cancer of exocrine pancreas

determination method

CIViC evidence level B

CIViC 3-star trust rating

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/1311

Somatic mutations in exocrine pancreatic tumors: association with patient survival

Identifiers

CIViC variant ID

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

dbSNP Reference SNP number

1 reference

HGVS nomenclature

NM_004985.4:c.35G>A

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

NP_004976.2:p.Gly12Asp

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

NC_000012.11:g.25398284C>T

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

ENST00000256078.4:c.35G>A

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/79

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28371012&oldid=2014798308"